2025 Mid-Atlantic Pharmacology Society (MAPS) Annual Meeting

Leon Passrelli-Roberts presented their recent findings at the 2025 Mid-Atlantic Pharmacology Society (MAPS) Annual Meeting, held at the University of Pennsylvania in Philadelphia.

Their work, showcased during the poster session, was titled:

"MAG Lipase Inibitor, JZL 184, Attenutates morphine presense preference via the CB1 receptors in the RMTg -> VTA pathway."

The event provided an excellent platform to engage with the dynamic Philadelphia pharmacological community, learn about cutting-edge regional research, and contribute to vital discussions on the future of the field.

We extend our gratitude to the MAPS organizers for a successful conference and look forward to providing further updates on this research shortly.